349 related articles for article (PubMed ID: 9474876)
41. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
Horn LC; Meinel A; Handzel R; Einenkel J
Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
[TBL] [Abstract][Full Text] [Related]
42. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
43. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
[TBL] [Abstract][Full Text] [Related]
44. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
45. [Pathological study of endometrial carcinogenesis in androgen-sterilized-rats].
Naito M; Morikawa S; Takeda B; Iwasawa H; Sekiya S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2561-6. PubMed ID: 6520476
[TBL] [Abstract][Full Text] [Related]
46. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical localization of glutathione S-transferase in preneoplastic and neoplastic lesions of the human uterine cervix.
Maguire NC; Drozd K; Luff RD; Kantor RR
Acta Cytol; 1991; 35(1):94-9. PubMed ID: 1994644
[TBL] [Abstract][Full Text] [Related]
48. A proposed model for endometrial serous carcinogenesis.
Zheng W; Xiang L; Fadare O; Kong B
Am J Surg Pathol; 2011 Jan; 35(1):e1-e14. PubMed ID: 21164282
[TBL] [Abstract][Full Text] [Related]
49. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
[TBL] [Abstract][Full Text] [Related]
50. Endometrial metaplasia of the uterine endocervix.
Yeh IT; Bronner M; LiVolsi VA
Arch Pathol Lab Med; 1993 Jul; 117(7):734-5. PubMed ID: 8323440
[TBL] [Abstract][Full Text] [Related]
51. [Primary squamous cell carcinomas of the endometrium. Clinico-pathologic data and histogenetic classification].
Horn LC; Bilek K
Zentralbl Pathol; 1993 Nov; 139(4-5):355-60. PubMed ID: 7510514
[TBL] [Abstract][Full Text] [Related]
52. The expression and localization of amylase in normal and malignant glands of the endometrium and endocervix.
Lee YS; Raju GC
J Pathol; 1988 Jul; 155(3):201-5. PubMed ID: 2457671
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological Characteristics and
Sung JY; Jung YY; Kim HS
Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
[TBL] [Abstract][Full Text] [Related]
54. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification.
Hendrickson MR; Kempson RL
Am J Surg Pathol; 1980 Dec; 4(6):525-42. PubMed ID: 7212146
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
56. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.
Ip PP
Virchows Arch; 2018 Jun; 472(6):907-917. PubMed ID: 29445890
[TBL] [Abstract][Full Text] [Related]
57. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.
Mai KT; Yazdi HM; Boone SA
Arch Pathol Lab Med; 1995 Aug; 119(8):751-4. PubMed ID: 7544107
[TBL] [Abstract][Full Text] [Related]
58. [Adenomatous hyperplasia of the corpus endometrium and the endocervix. Origin, severity and therapy].
Dallenbach-Hellweg G
Fortschr Med; 1976 Feb; 94(5):256-63. PubMed ID: 1254239
[TBL] [Abstract][Full Text] [Related]
59. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
60. Laminin immunostaining in hyperplastic, dysplastic, and neoplastic lesions of the endometrium and uterine cervix.
Vogel HP; Mendelsohn G
Obstet Gynecol; 1987 May; 69(5):794-9. PubMed ID: 2437505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
